Loading…
IPCA Laboratories (IPCALAB)₹1,960+1.08%Pharmaceuticals
At the end of the Jun 2026 quarter, IPCA Laboratories' shareholders were: promoters 44.68%, FIIs 10.66%, DIIs 37.05%, government 0.32%, public 7.29%. Promoter holding is unchanged on the quarter. FII holding is up 0.05 percentage points from 10.61% a year earlier. It had 82,036 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 46.25% | 46.25% | 46.26% | 46.26% | 46.26% | 44.68% | 44.68% | 44.68% | 44.68% | 44.68% | 44.68% | 44.68% |
| FIIs | 9.80% | 10.21% | 10.45% | 10.79% | 10.77% | 11.00% | 10.69% | 10.61% | 10.36% | 10.56% | 10.57% | 10.66% |
| DIIs | 34.73% | 34.20% | 34.06% | 33.47% | 33.91% | 35.37% | 35.74% | 35.89% | 36.46% | 37.00% | 37.14% | 37.05% |
| Government | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% |
| Public | 8.90% | 9.02% | 8.91% | 9.16% | 8.74% | 8.63% | 8.57% | 8.50% | 8.18% | 7.44% | 7.29% | 7.29% |
| Number of shareholders | 95,902 | 82,785 | 81,141 | 84,728 | 82,951 | 90,163 | 88,280 | 85,557 | 82,846 | 77,650 | 82,160 | 82,036 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Kaygee Investments Private Limited | Promoter | 25.54% | 0.00 |
| Hdfc Mutual Fund | DII | 9.55% | New |
| Kaygee Laboratories Private Limited | Promoter | 6.65% | 0.00 |
| Kotak Mahindra Mutual Fund | DII | 6.40% | New |
| Chandurkar Investments Private Limited | Promoter | 5.46% | 0.00 |
| DSP Mutual Fund | DII | 4.65% | New |
| Sbi Life Insurance Co. Ltd | DII | 3.68% | +0.11 |
| Nippon India Mutual Fund | DII | 2.77% | New |
| Premchand Godha | Promoter | 2.31% | 0.00 |
| Axis Mutual Fund | DII | 1.93% | New |
| Usha M Chandurkar | Promoter | 1.71% | 0.00 |
| Hdfc Life Insurance Company Limited | DII | 1.38% | −0.17 |
| Edelweiss Trusteeship Company Ltd | DII | 1.20% | New |
| Kotak Funds - India Midcap Fund | FII | 1.15% | −0.05 |
| Mfs International New Discovery Fund | FII | 1.04% | −0.03 |
| Hsbc Mutual Fund | DII | 1.04% | New |
| Usha Premchand Godha | Promoter | 0.95% | 0.00 |
| Sameer M Chandurkar | Promoter | 0.78% | 0.00 |
| Pranay Godha | Promoter | 0.67% | 0.00 |
| Prashant Godha | Promoter | 0.62% | 0.00 |
| Kalpana Jain | Promoter | 0.09% | 0.00 |
| Xbees Traders Llp | Promoter | 0.01% | 0.00 |
| Hdfc Mutual Fund - Hdfc Mid-Cap Fund | DII | Exited | — |
| Kotak Midcap Fund | DII | Exited | — |
| Dsp Midcap Fund | DII | Exited | — |
Promoters held 44.68% of IPCA Laboratories at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 10.66% (up 0.09 percentage points from 10.57% a quarter earlier) and domestic institutions (DIIs) held 37.05% (down 0.09 percentage points from 37.14% a quarter earlier).
IPCA Laboratories had 82,036 shareholders at the end of the Jun 2026 quarter, against 85,557 a year earlier.
Hdfc Mutual Fund (DII) held 9.55% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.